Pathological Basis of MRI Signal Changes in Multiple Sclerosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pathological Basis of MRI Signal Changes in Multiple Sclerosis — Stella

Recruiting

Back to Multiple Sclerosis trials

Trial locations(1 site)

United States

National Institutes of Health Clinical Center, Bethesda, Maryland

Key details

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~250 participants

Started

April 2016

Primary completion

February 2080

Age range

18 Years – 120 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov